Hvsen Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 188 million yuan, an increase of 494.28%
I'm PortAI, I can summarize articles.
Hvsen Biotech released its Q3 2025 report, with operating revenue for the first three quarters reaching 1.26 billion yuan, a year-on-year increase of 58.92%; net profit attributable to the parent company was 188 million yuan, a year-on-year increase of 494.28%; net profit excluding non-recurring gains and losses was 166 million yuan, a year-on-year increase of 611.92%; basic earnings per share were 1.0134 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments